Latest news and research outcomes

We have each met or likely know someone in their 80s or beyond, who appears happily young at heart, brighter and fitter than their advanced years. These lucky folk are what scientists term “super-agers” - defined as individuals aged over 80 with mental faculties that...

Hearing Loss May Hasten Cognitive Decline More Than We Think Hearing loss can seem just like an inevitable part of ageing for some. However, the evidence is more serious. Untreated hearing loss is now recognised as one of the most significant modifiable risk factors...

Green Light for First Blood Test to Diagnose Alzheimer’s Disease in the USA The U.S. Food and Drug Administration (FDA) recently approved the first test to use a blood sample to diagnose Alzheimer’s disease. [1] The earlier Alzheimer’s disease can be diagnosed, the...

18 September 2025 | 1 pm London | 8 am New York Join Alzheimer's Disease International (ADI) again for their annual launch of the World Alzheimer Report on 18 September 2025. This year is focusing on the essential, yet often overlooked, area of dementia...

Why are people so excited about donanemab? Donanemab is the first drug to be approved in Australia that alters the course of Alzheimer's disease. Previous medications have only helped to manage the symptoms of Alzheimer’s disease. How does it work? Donanemab is given...

Researchers have uncovered the strongest evidence yet that the shingles vaccination may reduce the risk of developing dementia1. The work published in Nature last month, took advantage of a vaccination rollout that took place in Wales over a decade ago. The UK...